Monic Stuart
Technik-/Wissenschafts-/F&E-Leiter bei MARKER THERAPEUTICS, INC.
Profil
Monic Stuart is currently the Chief Medical Officer at Marker Therapeutics, Inc. Prior to this, he held the position of Senior Medical Director at Genentech, Inc. from 2004 to 2009.
He then served as the Vice President-Clinical Development at Geron Corp.
from 2011 to 2012.
Dr. Stuart completed his graduate degree at The Johns Hopkins University and holds undergraduate and doctorate degrees from the University of North Carolina at Chapel Hill.
Aktive Positionen von Monic Stuart
| Unternehmen | Position | Beginn |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 08.05.2023 |
Ehemalige bekannte Positionen von Monic Stuart
| Unternehmen | Position | Ende |
|---|---|---|
| GERON CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2012 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2009 |
Ausbildung von Monic Stuart
| University of North Carolina at Chapel Hill | Doctorate Degree |
| The Johns Hopkins University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MARKER THERAPEUTICS, INC. | Health Technology |
| GERON CORPORATION | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
